{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:10:39Z","timestamp":1778735439339,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The diagnosis of bacterial infections (BIs) in patients with acute-on-chronic liver failure (ACLF) remains a formidable clinical challenge, directly impacting mortality rates. Current biomarkers are often confounded by the profound systemic inflammation inherent to ACLF itself. The objective of this study was to evaluate the diagnostic and prognostic utility of serum Delta-like ligand 1 (DLL1) in ACLF patients with BIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective diagnostic study utilized a pre-established, prospectively maintained ACLF cohort (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f168). Serum DLL1 levels were measured with enzyme-linked immunosorbent assays, and diagnostic performance was assessed via receiver operating characteristic (ROC) curve analysis and multivariable regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the ACLF cohort, serum DLL1 concentrations were significantly elevated in BI patients compared with their noninfected counterparts (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). Multivariable regression revealed that DLL1 was an independent diagnostic predictor (adjusted OR\u202f=\u202f1.982, 95% CI: 1.338\u20132.937). Moreover, the serum DLL1 level demonstrated substantial discriminative capacity (AUC\u202f=\u202f0.815; 95% CI: 0.750\u20130.879), which improved when this variable was synergistically incorporated into a CRP-DLL1 dual-marker model (AUC\u202f=\u202f0.852;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.039 versus DLL1 alone). The stability of the combined model was further evaluated in subgroups with available procalcitonin (PCT) data. Decision curve analysis confirmed the clinical net benefit between probability thresholds from 10 to 70%. Crucially, the levels of DLL1 exhibited only marginal correlations with hepatic function parameters, indicating minimal confounding from liver inflammation, but failed to independently predict mortality in patients with ACLF and BI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Serum DLL1 represents a robust and clinically deployable diagnostic biomarker for BI in patients with ACLF, and its performance is minimally affected by underlying hepatic dysfunction. The synergistic CRP-DLL1 dual-marker model demonstrated enhanced diagnostic discrimination, significantly outperforming the individual biomarkers. Notably, the DLL1 level was not an independent predictor of mortality in this population with concurrent infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1735014","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:27:53Z","timestamp":1778732873000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the diagnostic and prognostic utility of serum DLL1 in acute-on-chronic liver failure patients with bacterial infections"],"prefix":"10.3389","volume":"13","author":[{"given":"Juanjun","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital)","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital)","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Central Laboratory, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital)","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Ganzhou Hospital-Nanfang Hospital, Southern Medical University (Ganzhou People's Hospital)","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2023.04.021","article-title":"EASL clinical practice guidelines on acute-on-chronic liver failure","volume":"79","author":"Moreau","year":"2023","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","article-title":"Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure","volume":"74","author":"Wong","year":"2021","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41467-024-46047-8","article-title":"BTLA contributes to acute-on-chronic liver failure infection and mortality through CD4+ T-cell exhaustion","volume":"15","author":"Yu","year":"2024","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1053\/j.gastro.2014.11.045","article-title":"Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK","volume":"148","author":"Bernsmeier","year":"2015","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"European Foundation for the Study of chronic liver failure. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.14218\/JCTH.2024.00137","article-title":"Bacterial infections in acute-on-chronic liver failure: epidemiology, diagnosis, pathogenesis, and management","volume":"12","author":"Xu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e0138566","DOI":"10.1371\/journal.pone.0138566","article-title":"Procalcitonin identifies cell injury, not bacterial infection, in acute liver failure","volume":"10","author":"Rule","year":"2015","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s40121-020-00362-x","article-title":"Early diagnostic biomarkers of sepsis for patients with acute-on-chronic liver failure: a multicenter study","volume":"10","author":"Chen","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.3390\/jcm11185410","article-title":"The role of presepsin and procalcitonin in early diagnosis of bacterial infections in cirrhotic patients with acute-on-chronic liver failure","volume":"11","author":"Igna","year":"2022","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e70120","DOI":"10.1002\/iid3.70120","article-title":"Diagnostic and prognostic value of serum golgi protein 73 in patients with hepatitis B virus-associated acute-on-chronic liver failure","volume":"13","author":"Xu","year":"2025","journal-title":"Immunity Inflamm Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40121-021-00454-2","article-title":"Development and validation of a clinical predictive model for bacterial infection in hepatitis B virus-related acute-on-chronic liver failure","volume":"10","author":"Zhang","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrm.2016.94","article-title":"Notch signalling in context","volume":"17","author":"Bray","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"106557","DOI":"10.1016\/j.micpath.2024.106557","article-title":"The role of the notch signaling pathway in bacterial infectious diseases","volume":"188","author":"Yin","year":"2024","journal-title":"Microb Pathog"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fcimb.2018.00241","article-title":"The interplay of notch signaling and STAT3 in TLR-activated human primary monocytes","volume":"8","author":"Hildebrand","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1016\/j.celrep.2018.07.033","article-title":"Large-scale human dendritic cell differentiation revealing notch-dependent lineage bifurcation and heterogeneity","volume":"24","author":"Balan","year":"2018","journal-title":"Cell Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"766713","DOI":"10.3389\/fphys.2021.766713","article-title":"Notch ligand delta-like 1 is associated with loss of vascular endothelial barrier function","volume":"12","author":"Moll","year":"2021","journal-title":"Front Physiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"13355","DOI":"10.1038\/s41598-022-17778-9","article-title":"Delta-like canonical notch ligand 1 is predictive for sepsis and acute kidney injury in surgical intensive care patients","volume":"12","author":"Schneck","year":"2022","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"9164","DOI":"10.3390\/ijms24119164","article-title":"Evaluation of the novel sepsis biomarker host-derived delta-like canonical notch ligand 1\u2014a secondary analysis of 405 patients suffering from inflammatory or infectious diseases","volume":"24","author":"H\u00f6lle","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fcimb.2019.00267","article-title":"Host-derived delta-like canonical notch ligand 1 as a novel diagnostic biomarker for bacterial sepsis-results from a combinational secondary analysis","volume":"9","author":"Hildebrand","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"894","DOI":"10.3390\/diagnostics10110894","article-title":"Delta-like canonical notch ligand 1 in patients following liver transplantation-a secondary analysis of a prospective cohort study","volume":"10","author":"Decker","year":"2020","journal-title":"Diagnostics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: acute disease quality initiative (ADQI) and international club of ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3350\/cmh.2021.0169","article-title":"Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: a multicenter study","volume":"28","author":"Kim","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"67","author":"Wu","year":"2018","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/liv.13568","article-title":"Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality","volume":"38","author":"M\u00fccke","year":"2018","journal-title":"Liver Int"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"106458","DOI":"10.1016\/j.jinf.2025.106458","article-title":"Host-derived delta-like canonical notch ligand-1 in sepsis and septic shock: infection site, pathogens and disease severity matter \u2013 secondary analysis of data from a randomized controlled trial","volume":"90","author":"Theobald","year":"2025","journal-title":"J Infect"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"00368504251358310","DOI":"10.1177\/00368504251358310","article-title":"A serum DLL1 and CRP dual-marker model for bacterial infection detection in patients with decompensated cirrhosis: a dual-cohort diagnostic study","volume":"108","author":"Huang","year":"2025","journal-title":"Sci Prog"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3748\/wjg.v26.i32.4857","article-title":"Development of a novel score for the diagnosis of bacterial infection in patients with acute-on-chronic liver failure","volume":"26","author":"Lin","year":"2020","journal-title":"World J Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.diagmicrobio.2014.03.029","article-title":"Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"80","author":"Lin","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e002396","DOI":"10.1136\/bmjgh-2020-002396","article-title":"The good and the bad: using C reactive protein to distinguish bacterial from non-bacterial infection among febrile patients in low-resource settings","volume":"5","author":"Escadafal","year":"2020","journal-title":"BMJ Glob Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"6903","DOI":"10.3390\/ijms22136903","article-title":"Predictive ability of procalcitonin for acute kidney injury: a narrative review focusing on the interference of infection","volume":"22","author":"Kan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jhep.2024.09.046","article-title":"Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance","volume":"82","author":"Lee","year":"2025","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s12072-021-10268-6","article-title":"Establishment and validation of a prognostic model for hepatitis B virus-related acute-on-chronic liver failure patients with bacterial infection","volume":"16","author":"Zhang","year":"2022","journal-title":"Hepatol Int"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1189\/jlb.1011529","article-title":"Notch system in the linkage of innate and adaptive immunity","volume":"92","author":"Ito","year":"2012","journal-title":"J Leukoc Biol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e57007","DOI":"10.7554\/eLife.57007","article-title":"Notch and TLR signaling coordinate monocyte cell fate and inflammation","volume":"9","author":"Gamrekelashvili","year":"2020","journal-title":"eLife"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms24043458","article-title":"Notch signaling in acute inflammation and sepsis","volume":"24","author":"Gallenstein","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MOH.0000000000000425","article-title":"NOTCH regulation of the endothelial cell phenotype","volume":"25","author":"Mack","year":"2018","journal-title":"Curr Opin Hematol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1735014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:27:57Z","timestamp":1778732877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1735014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":41,"alternative-id":["10.3389\/fmed.2026.1735014"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1735014","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"article-number":"1735014"}}